In order to further relate the increase of miR-21 that we observed after stimulating primary CLL cells with microenviromental stimuli with BCR signaling we inhibited this pathway with the widely used BTK inhibitor ibrutinib, which caused a marked impairment in the upregulation of miR-21. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.